Phase III trials articles from across Nature Portfolio

Phase III trials are conducted to provide stronger evidence of the effectiveness and safety of a therapeutic intervention and typically form a key part of applications to regulatory authorities to grant market approval. They usually involve 500-3000 or more patients and compare the therapeutic intervention with the current standard of care for patients with the disease intended to be treated.

Latest Research and Reviews

News and Comment